Book a demo

Cut patent&paper research from weeks to hours with PatSnap Eureka AI!

Try now
Russ v. Nike: US6639128B1 Plant Biology Patent Dismissed | PatSnap
Explore in Eureka
Case ID3:25-cv-00876
FiledMay 2025
ClosedAug 2025
Patent Litigation

Russ v. Nike: Plant Biology Patent Claim Dismissed With Prejudice in 82 Days

Jamaal Russ filed suit against Nike in the Oregon District Court asserting US6639128B1, a patent covering methods for altering organ mass and controlling fertility in plants. The case ended when the court dismissed all claims with prejudice under FRCP 41(b) after Russ failed to amend his petition following an earlier dismissal with leave to amend — closing the matter permanently in just 82 days.

Resolution time
82days
82 days — well below the median federal patent case duration of 2–3 years
Patents asserted
1
US6639128B1 — methods for altering organ mass, controlling fertility and enhancing asexual reproduction in plants
Outcome
Dismissed with Prejudice
Dismissed with prejudice under FRCP 41(b) — claims permanently barred; no refiling permitted
Cost ruling
Costs: N/A
No costs or fee award recorded in the public docket for this proceeding
Published by PatSnap Insights Team · Verified by PatSnap Eureka Data
Case overview

Pro Se Plant Patent Suit Against Nike Ends in Permanent Dismissal

On 22 May 2025, Jamaal Russ, appearing to proceed pro se, filed an infringement action in the U.S. District Court for the District of Oregon (Case No. 3:25-cv-00876) against Nike. The asserted patent, US6639128B1 (application no. US09/479855), covers methods for altering organ mass, controlling fertility, and enhancing asexual reproduction in plants — a technical domain that appears facially incongruent with Nike’s core consumer goods and footwear business.

Judge Karin J. Immergut first dismissed the petition with leave to amend (ECF 14), providing Russ an opportunity to cure deficiencies in the pleading. Russ did not file an amended petition. The court accordingly entered final judgment dismissing all claims with prejudice under Federal Rule of Civil Procedure 41(b) for failure to prosecute. A dismissal with prejudice under Rule 41(b) operates as an adjudication on the merits, permanently foreclosing Russ from re-filing the same claims against Nike in any federal court.

The 82-day lifespan of this case is consistent with early-stage dismissals where a complaint fails to survive initial judicial scrutiny. The public record does not disclose the specific pleading deficiencies identified in ECF 14, nor Nike’s litigation response, if any. What is notable is that the court extended a curative opportunity that went unused — suggesting the claim may have faced fundamental sufficiency issues that the plaintiff could not or chose not to address.

Case at a glance
Case no.3:25-cv-00876
PlaintiffJamaal Russ
DefendantNike
CourtOregon
JudgeKarin J. Immergut
FiledMay 22, 2025
ClosedAugust 12, 2025
Duration82 days
OutcomeDismissed with Prejudice
Verdict causeInfringement Action
BasisDismissed with Prejudice
Prior Art Intelligence
See what prior art exists on this patent.
Eureka scans millions of patents and papers to surface prior art that may have invalidated these claims before costly litigation begins.
Check Prior Art
Case data sourced from PACER / Oregon District Court via PatSnap Eureka Litigation Intelligence Explore similar cases ↗
Case timeline

Filing to Dismissed with Prejudice in 82 days

82 days — well below the median federal patent case duration of 2–3 years

Case timeline: Complaint filed MAY 22 2025, JUL–AUG — 82 days total Horizontal timeline showing the three key events in Jamaal Russ v Nike from filing to resolution. Source: PACER, Oregon District Court. MAY 22 2025 Complaint filed Pre-trial proceedings AUG 12 2025 Dismissed with Prejudice 82 DAYS TOTAL
Dismissal terms

Dismissed with prejudice: what the Rule 41(b) ruling means for both parties

Legal mechanism

Rule 41(b) dismissal with prejudice: the claim is permanently closed

FRCP 41(b) empowers a court to dismiss an action with prejudice when a plaintiff fails to prosecute or comply with a court order. Unlike a voluntary dismissal, this is an involuntary court-ordered termination. Critically, a Rule 41(b) dismissal with prejudice operates as a final adjudication on the merits — Russ cannot refile these claims against Nike in federal court based on the same patent and alleged conduct.

Involuntary dismissal — merits bar
Plaintiff outcome

Russ loses all claims permanently — no further avenue on these facts

The dismissal with prejudice extinguishes Russ’s ability to reassert US6639128B1 against Nike for the alleged infringing conduct at issue. The court granted leave to amend, but the opportunity was not taken. The public record does not explain why Russ failed to amend, but the outcome is unambiguous: the claims are permanently barred. Any future assertion against Nike would need to be grounded in entirely new facts or a separate patent.

Claims permanently extinguished
Defendant outcome

Nike prevails without recorded substantive defence costs

Nike emerges from this case with a final judgment in its favour. Because dismissal was entered on procedural failure-to-prosecute grounds rather than following contested merits proceedings, Nike’s litigation exposure was minimal. No defendant agents or law firm are recorded in the public docket, suggesting the case may have resolved before Nike mounted a formal defence. The with-prejudice bar protects Nike from re-exposure on the same claims.

Defendant protected by prejudice bar
Commercial implications

Minimal IP risk to Nike — but plant patent enforcement patterns warrant monitoring

This case presents no apparent commercial IP risk to Nike given the subject matter disconnect between a plant biology methods patent and a footwear/apparel business. However, the case is a reminder that any patent holder — including those asserting facially incongruent patents — can initiate costly litigation. Companies with large Oregon-based operations should maintain docket monitoring for unusual patent filings as part of routine IP risk hygiene.

Low commercial IP risk to Nike
Legal analysis based on PACER docket records for case 3:25-cv-00876 and PatSnap Eureka litigation intelligence Search PatSnap Eureka ↗
Parties and representation

Full party and counsel information

RoleNameTypeDetail
PlaintiffJamaal RussIndividualPro se litigant — holder of US6639128B1 covering plant biology methodsSearch in Eureka ↗
DefendantNikeIndividualNike — global footwear and athletic apparel company headquartered in OregonSearch in Eureka ↗
Plaintiff counselJamaal RussAttorneyCounsel for Jamaal RussSearch in Eureka ↗
Presiding judgeJudge Karin J. ImmergutJudgeOregon District CourtSearch in Eureka ↗
Official verdict

Official order — verbatim text

“Based on this Court’s Order Dismissing Plaintiff’s Petition with leave to amend, ECF 14, and Plaintiff’s failure to amend his petition, IT IS ADJUDGED that Plaintiff’s claims are dismissed with prejudice for failure to prosecute under Federal Rule of Civil Procedure 41(b).”
Source: PACER Docket, Case 3:25-cv-00876, Oregon District Court

The verdict language is precise and consequential: the court first issued an order dismissing the petition with leave to amend (ECF 14), establishing that the original complaint was substantively deficient. Russ’s subsequent inaction triggered Rule 41(b), which treats failure to comply with a court order as grounds for final dismissal. The with-prejudice designation means the judgment carries full claim-preclusive effect — identical claims against Nike arising from the same patent and conduct cannot be re-filed. No merits ruling on US6639128B1’s validity or Nike’s alleged infringement was reached.

PACER case 3:25-cv-00876 · Public docket record Explore in Eureka ↗
Patent at issue

US6639128B1 — Methods for altering organ mass and plant fertility

Publication No.US6639128B1
Application No.US09/479855
Patent details
ProductMethods for altering organ mass, controlling fertility and enhancing asexual reproduction in plants
Cited in actionMay 22, 2025

US6639128B1 (application no. US09/479855) is a utility patent covering methods directed at altering organ mass, controlling fertility, and enhancing asexual reproduction in plants. This falls within the agricultural biotechnology and plant science domain — an area with commercial relevance to seed companies, agrochemical firms, and horticultural biotechnology developers. The patent’s technical claims relate to biological manipulation of plant physiology rather than industrial manufacturing or consumer goods.

The strategic relevance of US6639128B1 lies primarily in the agricultural biotech sector, not consumer apparel. For IP professionals, this case is a reminder that patents can be asserted outside their natural competitive landscape. Organisations operating in plant science, precision agriculture, or seed technology sectors should conduct freedom-to-operate assessments against this patent, particularly given that no merits ruling was reached in this case — leaving the patent’s validity and enforceability legally unexamined by this court.

Patent data sourced from USPTO via PatSnap Eureka patent database Search patent records in Eureka ↗
Freedom to operate

Should you run an FTO analysis against US6639128B1?

Any company developing, commercialising, or licensing technologies related to plant organ mass modification, fertility control, or asexual propagation enhancement should assess exposure to US6639128B1. The patent’s validity was never adjudicated in Russ v. Nike — meaning it remains nominally enforceable. Agricultural biotech firms, seed developers, and horticultural technology companies should treat this as a live FTO consideration until a reexamination or inter partes review determines otherwise.

PatSnap Eureka’s FTO Search Agent can map US6639128B1’s independent claims against your product or process workflow, identify prior art that may challenge claim validity, and surface any related continuation or divisional filings in the same patent family. Running an Eureka FTO analysis before launching plant biotechnology products reduces the risk of facing infringement assertions — even procedurally weak ones that impose real litigation costs before dismissal.

PatSnap Eureka FTO Search

Run a freedom-to-operate analysis on US6639128B1 to assess your product’s exposure

Run FTO in Eureka →
Related litigation

Similar plant biology patent suits in Oregon federal courts

Explore comparable patent infringement cases involving plant science and agricultural biotechnology patents filed in the Oregon District Court and Ninth Circuit.

🔍
Access 40+ similar cases in PatSnap Eureka
Jamaal Russ patent enforcement history, Oregon case history, Jamaal Russ’s full IP portfolio, and comparable case analysis
Other pro se patent suits vs NikePlant biotech FRCP 41(b) dismissalsOregon District Court patent trendsUS6639128B1 related filings
Unlock similar cases in Eureka →
Strategic implications

What this case signals for the patent enforcement IP landscape

A 82-day dismissal with prejudice after failed amendment illustrates how quickly federal courts can close out deficient pro se patent suits.

Courts will grant curative leave to amend — but failure to act is permanently fatal

Judge Immergut’s decision to dismiss with leave to amend before entering Rule 41(b) judgment reflects standard due-process practice. However, once that window closes unused, the prejudice bar is absolute. IP defendants facing pro se suits should monitor amendment deadlines closely — non-compliance typically triggers swift final dismissal without further merits exposure.

Subject-matter incongruence does not prevent a lawsuit from being filed

US6639128B1 covers plant biology methods. Nike makes footwear and apparel. The technological disconnect did not prevent this suit from being filed and consuming court resources for 82 days. IP risk programmes at large consumer goods companies should include automated docket alerts for any patent assertion, regardless of apparent relevance.

🔒
Full strategic analysis in PatSnap Eureka
Unlock gated insights on pro se patent enforcement trends in Oregon District Court and Nike’s IP defence posture.
Res judicata scopePro se filing patternsRule 12 rapid defence playbook
Unlock full analysis →
Analysis powered by PatSnap Eureka Litigation Intelligence Explore in Eureka ↗
Frequently asked questions

Russ v Nike — key questions answered

Still have questions? PatSnap Eureka can answer them instantly from patent and litigation data. Ask Eureka ↗
PatSnap Eureka

Run your FTO analysis on plant biology patents before it becomes a dispute

US6639128B1 was never invalidated or adjudicated on the merits. PatSnap Eureka helps R&D and IP teams assess exposure to active plant biotech patents, monitor new assertions, and build FTO reports before litigation risk materialises.

Ask anything about this case.
PatSnap Eureka searches patents and litigation data to answer instantly.
Powered by PatSnap Eureka
Link copied to clipboard

Related Litigation Cases

Help us improve this page

Found incorrect or outdated information? Let us know and we'll get it fixed.